Palisade Bio, Inc. (PALI)
Nasdaq: PALI · Biological Products, (No Diagnostic Substances) · Carlsbad, CA · filing with the SEC since 2006
Who owns Palisade Bio, Inc.
As filed with the SECHolders of 5% or more
8
Janus Henderson Group PLC holds 9.99% of Common Stock, as its SCHEDULE 13G filed Dec 8, 2025 says.
Directors and officers
8
report now, of 26 people on the record since 2007. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 8 named at left.
Holders of 5% or moreshare of the class, as filed
Janus Henderson Group PLC
SCHEDULE 13G · filed Dec 8, 2025 · Common Stock
RA Capital Management, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.01 per share · 9.9% in Feb 17, 2026
Perceptive Advisors LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.01 par value · 9.99% in Feb 17, 2026
Soleus Capital Master Fund, L.P.
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock, $0.01 par value per share · 5.4% in May 27, 2026
Octagon Capital Advisors LP
SCHEDULE 13G · filed Feb 10, 2026 · Common Stock, $0.01 par value
Blackrock, Inc.
SCHEDULE 13G · filed Jul 29, 2026 · Common Stock
Franklin Resources, Inc.
SCHEDULE 13G · filed Jan 29, 2026 · Common Stock, par value $0.01
Ameriprise Financial, Inc.
SCHEDULE 13G · filed May 15, 2026 · Common Stock
Armistice Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, $0.01 par value · reported falling below 5%, from 9.99% in May 15, 2025
Squadron Master Fund LP
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%, from 8.5% in Oct 8, 2025
Point72 Asset Management, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%, from 7% in Feb 17, 2026
Commodore Capital LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%, from 7.2% in May 15, 2026
Deep Track Capital, LP
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%, from 9.99% in Oct 8, 2025
What PALI reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 22, 2023.
Insider tradesForm 4
4sales
10purchases
0sales on a scheduled plan
2people selling
$400,000sold, in dollars
$300,000bought, in dollars
Open-market trades on Form 4 from Oct 21, 2025 to Oct 21, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 21, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 27 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Finley John David | CEO CFO | 2 | $300,000 | 0 | 0 | $0 |
| Jones Mitchell Lawrence | See Remarks | 2 | $100,000 | 0 | 0 | $0 |
| Baltera Robert Jr. | director | 0 | $0 | 0 | 6 | $300,000 |
| Williams Donald Allen | director | 0 | $0 | 0 | 4 | $0 |